ATC codes: L01BB02
Lymphoid leukaemia, not elsewhere classified ICD11 code: 2C03.3
Oral > Solid: 50 mg tablet
EML status history
Also recommended for children
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for mercaptopurine on the complementary list of the EML and EMLc for use in treatment protocols for acute lymphoblastic leukaemia was endorsed. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for acute lymphoblastic leukaemia is attached.